ERA-EDTA Symposium 2018

Read story

ESC Congress 2017

Read story

ERA-EDTA Congress 2017

Read story

ESC Congress 2016

Read story

EASD 2016

Read story

European Biopharmaceutical Review

Read story

New York Academy of Science Symposium

Read story

The Complement System: Part 1

Read story

The Complement System: Part 2

Read story

The Complement System: Part 3

Read story

Diabetes Mellitus

Read story

Chronic Kidney Disease

Read story

The New Frontier of Epigenetics

Read story

Readers, Writers & Erasers in Epigenetics

Read story

Clinical Trials Series: Part 1

Read story

Clinical Trials Series: Part 2

Read story

Clinical Trials Series: Part 3

Read story

Pharmacoeconomics

Read story

Sanofi Biogenius Competition CTV News feature

Read story

World Diabetes Day

Read story

ESC Congress 2017

On August 26, 2017, Resverlogix supported a satellite symposium at the at the European Society of Cardiology (ESC) Congress in Barcelona, Spain: "Managing Diabetes & CVD: Is epigenetics a new way forward?"

Symposium Agenda

Introduction - Lina Badimon, MD – Barcelona, Spain.

Stephen Nicholls, MD - Adelaide, Australia. "Insights from the first trials in epigenetics in human: What is the way forward?"

Erik Stroes, MD - Academic Medical Centre, Amsterdam, Netherlands. "Promise of epigenetic modulation as a target in atherosclerotic patients."

Kausik Ray, MD - Imperial College London, United Kingdom. "The Clinical Unmet need in the patient with Diabetes and ACS?"

Video Presentations & Symposium Highlights can be accessed HERE